A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants

Clinical trial NCT07221084 · COMPLETED

Trial details

NCT number: NCT07221084
Sponsor: Crinetics Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-10-28
Primary completion: 2026-02-07
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.